Both in Pharmaceuticals
Kyntra Bio vs Pasithea Therapeutics
Over the past year KYNB returned −58.3% and KTTA returned −42.5%; their daily moves had a correlation of 0.05.
KYNB −58.3% KTTA −42.5%Growth of $1, one year, split-adjusted
| Metric | KYNB | KTTA |
|---|---|---|
| Price | $3.96 | $0.5300 |
| Market cap | $16.0M | $17.7M |
| Today | −8.12% | 0.00% |
| 1 month | −33.6% | +18.6% |
| 6 months | −44.4% | −37.6% |
| Year to date | — | −58.9% |
| 1 year | — | −35.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $91.3M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.0% | 103.5% |
| Short % of float | 2.5% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).